These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia. Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845 [TBL] [Abstract][Full Text] [Related]
8. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks. Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154 [TBL] [Abstract][Full Text] [Related]
9. Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in prediction of pre-eclampsia. Andrietti S; Carlucci S; Wright A; Wright D; Nicolaides KH Ultrasound Obstet Gynecol; 2017 Aug; 50(2):221-227. PubMed ID: 28078815 [TBL] [Abstract][Full Text] [Related]
10. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting. Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562 [TBL] [Abstract][Full Text] [Related]
11. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425 [TBL] [Abstract][Full Text] [Related]
13. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study. Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323 [TBL] [Abstract][Full Text] [Related]
14. Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies. Anderson N; De Laat M; Benton S; von Dadelszen P; McCowan L Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):89-95. PubMed ID: 29851029 [TBL] [Abstract][Full Text] [Related]
15. Addition of N-terminal pro-B natriuretic peptide to soluble fms-like tyrosine kinase-1/placental growth factor ratio > 38 improves prediction of pre-eclampsia requiring delivery within 1 week: a longitudinal cohort study. Sabriá E; Lequerica-Fernández P; Lafuente-Ganuza P; Eguia-Ángeles E; Escudero AI; Martínez-Morillo E; Barceló C; Álvarez FV Ultrasound Obstet Gynecol; 2018 Jun; 51(6):758-767. PubMed ID: 29498431 [TBL] [Abstract][Full Text] [Related]
18. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia. Vandenberghe G; Mensink I; Twisk JW; Blankenstein MA; Heijboer AC; van Vugt JM Prenat Diagn; 2011 Oct; 31(10):955-61. PubMed ID: 21717483 [TBL] [Abstract][Full Text] [Related]
19. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Poon LC; Zaragoza E; Akolekar R; Anagnostopoulos E; Nicolaides KH Prenat Diagn; 2008 Dec; 28(12):1110-5. PubMed ID: 19003787 [TBL] [Abstract][Full Text] [Related]
20. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies. Saleh L; Tahitu SIM; Danser AHJ; van den Meiracker AH; Visser W Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]